← Every applicant
Epic Pharma LLC FDA Approvals
18 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| RIVAROXABANNew drugAug 19, 2026TABLET, ORAL |
| CETRORELIX ACETATENew drugApr 29, 2026POWDER, SUBCUTANEOUS |
| OXCARBAZEPINENew drugMar 2, 2026TABLET, ORAL |
| TAPENTADOL HYDROCHLORIDENew drugJan 27, 2026TABLET, ORAL |
| IVERMECTINNew drugSep 9, 2025TABLET, ORAL |
| BUCAPSOLNew drugMar 13, 2025CAPSULE, ORAL |
| ESOMEPRAZOLE SODIUMNew drugJan 8, 2025INJECTABLE, INTRAVENOUS |
| CYCLOPHOSPHAMIDENew drugDec 19, 2024INJECTABLE, INJECTION |
| FAMOTIDINENew drugOct 16, 2024FOR SUSPENSION, ORAL |
| URSODIOLNew drugAug 14, 2024TABLET, ORAL |
| ACETAZOLAMIDENew drugMay 14, 2024TABLET, ORAL |
| DIFLUPREDNATENew drugMay 14, 2024EMULSION, OPHTHALMIC |
| GABAPENTINNew drugFeb 26, 2024TABLET, ORAL |
| PREGABALINNew drugJun 1, 2023TABLET, EXTENDED RELEASE, ORAL |
| OSELTAMIVIR PHOSPHATENew drugFeb 14, 2023FOR SUSPENSION, ORAL |
| OSELTAMIVIR PHOSPHATENew drugOct 1, 2021CAPSULE, ORAL |
| PAROXETINE HYDROCHLORIDENew drugAug 11, 2021TABLET, EXTENDED RELEASE, ORAL |
| DICLOFENAC SODIUMNew drugJan 28, 2021SOLUTION, TOPICAL |